指南与共识心血管PET

心肌灌注PET检测与报告冠状动脉微血管功能障碍:JACC心血管影像专家小组声明

Myocardial Perfusion PET for the Detection and Reporting of Coronary Microvascular Dysfunction: A JACC: Cardiovascular Imaging Expert Panel Statement.
PubMed 文献 · JACC Cardiovasc Imaging · 2023-02-08

该专家小组声明针对正常或非阻塞性冠状动脉患者的心绞痛和呼吸困难诊断难题,提出用PET定量静息和充血性心肌血流量及心肌血流储备无创检测冠状动脉微血管功能障碍,并标准化诊断、命名和报告标准。声明将PET测定的功能和储备分为「经典」和「内源性」正常或障碍,以指导个体化治疗决策。

要点

  • 对正常或非阻塞性冠状动脉患者,应怀疑冠状动脉微血管功能障碍。
  • PET定量心肌血流量和心肌血流储备可无创检测冠状动脉微血管功能障碍。
  • 标准化诊断和报告标准有助于优化个体化治疗决策。
英文原文(摘要)· 点击展开

Angina pectoris and dyspnea in patients with normal or nonobstructive coronary vessels remains a diagnostic challenge. Invasive coronary angiography may identify up to 60% of patients with nonobstructive coronary artery disease (CAD), of whom nearly two-thirds may, in fact, have coronary microvascular dysfunction (CMD) that may account for their symptoms. Positron emission tomography (PET) determined absolute quantitative myocardial blood flow (MBF) at rest and during hyperemic vasodilation with subsequent derivation of myocardial flow reserve (MFR) affords the noninvasive detection and delineation of CMD. Individualized or intensified medical therapies with nitrates, calcium-channel blockers, statins, angiotensin-converting enzyme inhibitors, angiotensin II type 1-receptor blockers, beta-blockers, ivabradine, or ranolazine may improve symptoms, quality of life, and outcome in these patients. Standardized diagnosis and reporting criteria for ischemic symptoms caused by CMD are critical for optimized and individualized treatment decisions in such patients. In this respect, it was proposed by the cardiovascular council leadership of the Society of Nuclear Medicine and Molecular Imaging to convene thoughtful leaders from around the world to serve as an independent expert panel to develop standardized diagnosis, nomenclature and nosology, and cardiac PET reporting criteria for CMD. This consensus document aims to provide an overview of the pathophysiology and clinical evidence of CMD, its invasive and noninvasive assessment, standardization of PET-determined MBFs and MFR into "classical" (predominantly related to hyperemic MBFs) and "endogen" (predominantly related to resting MBF) normal coronary microvascular function or CMD that may be critical for diagnosis of microvascular angina, subsequent patient care, and outcome of clinical CMD trials.

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Schindler, Fearon, Pelletier-Galarneau, et al. Myocardial Perfusion PET for the Detection and Reporting of Coronary Microvascular Dysfunction: A JACC: Cardiovascular Imaging Expert Panel Statement. JACC Cardiovasc Imaging. 2023. PMID: 36881418. doi:10.1016/j.jcmg.2022.12.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。